Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A better characterization of disinhibition in frontotemporal degeneration

Published on: 20/06/2022 Reading time: 1 min
cerveau
Retour à la recherche

Thanks to an approach combining behavioral assessment and brain imaging, a study conducted by the Paris Brain Institute's FrontLAB has led to a better characterization of a major symptom of frontotemporal degeneration, disinhibition. These results, published in Neuroimage: Clinical, pave the way for a more adapted and personalized management of patients and support for their caregivers.

Disinhibition, a major symptom of frontotemporal degeneration 

Disinhibition is a symptom of many neurodegenerative diseases, in particular those affecting the frontal regions of the brain such as fronto-temporal degeneration (FTD). FTD is the second most common cause of dementia after Alzheimer's disease. They can take different forms, including a variant called "behavioral", characterized by cognitive and behavioral disorders. Disinhibition is at the heart of these behavioral changes and disorders.

Two main types of disinhibition are commonly distinguished: cognitive disinhibition, which corresponds to an inability to block (inhibit) inappropriate responses or to stop responses already underway, and behavioral disinhibition, which is manifested by the inability to repress behaviors in an environment, in social contexts or to adapt to changes in one's environment.

"Despite these two relatively well-established definitions, there is still no way to accurately assess behavioral disinhibition in people with FTD other than through caregiver-completed questionnaires. Moreover, the neuroanatomical correlates of this symptom are not clearly defined," said Delphine Tanguy, first author of the study.

LA COMBINAISON D’UNE APPROCHE SEMI-ÉCOLOGIQUE ET DE L’IMAGERIE CÉRÉBRALE

Depuis près de 10 ans, l’Institut du Cerveau développe le programme ECOCAPTURE, conduit par Bénédicte Batrancourt (Inserm) et Richard Lévy (AP-HP-Sorbonne Université), qui vise à évaluer de façon objective et quantitative les symptômes neuropsychiatriques comme l’apathie et la désinhibition en conditions proches de la vie réelle (approche semi-écologique).

Afin de mieux définir la désinhibition chez les patients atteints de DFT, l’équipe FrontLAB de l’Institut du Cerveau a utilisé l’approche d’ECOCAPTURE pour évaluer avec de nouvelles métriques comportementales, deux composantes de la désinhibition : la compulsivité et la désinhibition sociale. Ils y ont associé de l’imagerie structurelle (IRM) et des questionnaires classiques d’évaluation cognitive comme le test de Hayling (mesure les capacités d’inhibition cognitive lors des réponses verbales spontanées) et des tests de cognition sociale.

The combination of a semi-ecological approach and brain imaging

For nearly 10 years, the Paris Brain Institute has been developing the ECOCAPTURE program, led by Bénédicte Batrancourt (Inserm) and Richard Lévy (AP-HP-Sorbonne University), which aims to objectively and quantitatively evaluate neuropsychiatric symptoms such as apathy and disinhibition under conditions close to real life (semi-ecological approach).

In order to better define disinhibition in FTD patients, the FrontLAB team of the Paris Brain Institute used the ECOCAPTURE approach to assess two components of disinhibition with new behavioral metrics: compulsivity and social disinhibition. They combined structural imaging (MRI) and classical cognitive assessment questionnaires such as the Hayling test (measures cognitive inhibition abilities during spontaneous verbal responses) and social cognition tests.

A better characterization of disinhibition in FTD patients

The researchers confirm that in patients with the behavioral variant of FTD, disinhibition is manifested on both components: compulsivity and social disinhibition. Moreover, the behavioral data collected through the semi-ecological approach are consistent with the results of the cognitive tests. Compulsivity observed in patients correlates with Hayling test scores. Furthermore, both compulsivity and social disinhibition are associated with the results of the social cognition and emotion recognition tests. Finally, the imaging data allow us to distinguish two different patterns of atrophy in the frontotemporal networks depending on the subtype of disinhibition: social disinhibition or compulsivity.

These results confirm the interest of the semi-ecological approach for the assessment of disinhibition. By characterizing more precisely the type of disinhibition affecting a patient, we can set up better management strategies for the patient and also support his or her caregiver, whose quality of life can be heavily impacted by this type of symptom

Lara Migliaccio Inserm

Source : An ecological approach to identify distinct neural correlates of disinhibition in frontotemporal dementia. Tanguy D, Batrancourt B, Estudillo-Romero A, Baxter JSH, Le Ber I, Bouzigues A, Godefroy V, Funkiewiez A, Chamayou C, Volle E, Saracino D, Rametti-Lacroux A, Morandi X, Jannin P, Levy R, Migliaccio R; ECOCAPTURE study group. Neuroimage Clin. 2022 Jun 7

Our news on the subject

Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
La bibliothèque de Babel
Mental Time Travel: A New Case of Autobiographical Hypermnesia
Remembering past events in minute detail, revisiting them methodically, and reliving past emotions—this is the peculiarity of people with an exceptional memory of their own lives, known as autobiographical hypermnesia, or hyperthymesia. This...
08.28.2025 Research, science & health
sequencage adn
Intellectual development disorders: two new genes under the microscope
A Franco-German international research team has identified two new genes that play a role in the onset of intellectual development disorders (IDD), also known as intellectual disabilities. Researchers have successfully developed two new types of test...
12.08.2025 Research, science & health
Troubles du Développement Intellectuel
The "RNU-Splice" project receives support from the health sponsorship of AXA Mutuals
Intellectual development disorders (IDD) affect 2 to 3 per cent of the population and are characterized by impaired cognitive functions, impacting learning. TDI thus has an impact on coping skills with implications for daily life and is a major...
10.08.2025 Support
See all our news